<- Go Home
CM Life Sciences, Inc.
As of July 22, 2021, CM Life Sciences, Inc. was acquired by Mount Sinai Genomics, Inc., in a reverse merger transaction. CM Life Sciences, Inc. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. The company focuses on targeting life science companies. CM Life Sciences, Inc. was incorporated in 2020 and is based in New York, New York.
Market Cap
$642.0M
Volume
191.1K
Cash and Equivalents
$1.1M
EBITDA
N/A
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
N/A
Profit Margin
N/A
52 Week High
$27.18
52 Week Low
$9.66
Dividend
N/A
Price / Book Value
128.40
Price / Earnings
N/A
Price / Tangible Book Value
128.40
Enterprise Value
N/A
Enterprise Value / EBITDA
N/A
Operating Income
-$412.4K
Return on Equity
N/A
Return on Assets
N/A
Cash and Short Term Investments
$1.1M
Debt
N/A
Equity
$5.0M
Revenue
N/A
Unlevered FCF
N/A
Sector
Capital Markets
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium